Investors

Financials

	2022	2021	2020	2019
Financial Statements	Q1 Q2 Q3 Q4	Q1 Q2 Q3 Q4	Q1 Q2 Q3 Q4	Q1 Q2 Q3 Q4
MD&A	Q1 Q2 Q3 Q4	Q1 Q2 Q3 Q4	Q1 Q2 Q3 Q4	Q1 Q2 Q3 Q4

Regulatory Filings

For a full list of Cardiol Therapeutics’ regulatory filings, please visit SEDAR (Canadian Public Filings) or EDGAR (US Public Filings).

Financial Downloads

	Cardiol Therapeutics – 2022 Year End Financial Statements
	Cardiol Therapeutics – 2022 Year End MD&A
	Cardiol Therapeutics – 2022 Annual Report on Form 20-F
	Cardiol Therapeutics – 2021 Year End Financial Statements
	Cardiol Therapeutics – 2021 Year End MD&A
	Cardiol Therapeutics – 2021 Annual Information Form
	Cardiol Therapeutics – 2020 Year End Financial Statements
	Cardiol Therapeutics – 2020 Year End MD&A
	Cardiol Therapeutics – 2019 Year End Financial Statements
	Cardiol Therapeutics – 2019 Year End MD&A
	Cardiol Therapeutics – 2018 Year End Financial Statements
	Cardiol Therapeutics – 2018 Year End MD&A